Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure

BACKGROUND: Metronidazole is the first-line treatment for bacterial vaginosis, but cure rates are suboptimal and recurrence rates high. OBJECTIVES: To evaluate the impact of a standard course of oral metronidazole treatment (500 mg twice per day for 7 days) on the vaginal microbiota of Rwandan bacte...

Descripción completa

Detalles Bibliográficos
Autores principales: Verwijs, Marijn C., Agaba, Stephen K., Darby, Alistair C., van de Wijgert, Janneke H.H. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995998/
https://www.ncbi.nlm.nih.gov/pubmed/31404542
http://dx.doi.org/10.1016/j.ajog.2019.08.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995998/
https://www.ncbi.nlm.nih.gov/pubmed/31404542
http://dx.doi.org/10.1016/j.ajog.2019.08.008

Ejemplares similares